In the largest genetic study of anxiety disorders to date, new research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London, in partnership with Texas A&M and the Institute of Psychiatric Phenomics and Genomics (IPPG) at LMU Munich, has identified 58 genetic variants associated with anxiety, most of which have not been identified before now.
By
NIHR Maudsley BRC at 3 Feb 2026
Researchers at King’s College London and the University of Florence have, for the first time, identified the specific genetic blueprint of mania, the defining feature of bipolar disorder.
By
NIHR Maudsley BRC at 28 Jan 2026
In 2025, NIHR Maudsley BRC delivered research with real-world impact from evaluating new treatments for depression and migraine to developing innovative approaches to monitoring opioid overdose and diagnosing eating disorders.
By
NIHR Maudsley BRC at 19 Dec 2025
Switching from one selective serotonin reuptake inhibitor (SSRI) to another antidepressant could be used to measure antidepressant non-response, according to new research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London.
By
NIHR Maudsley BRC at 28 May 2025
75% of a sample of nearly 20,000 people who have taken selective serotonin reuptake inhibitors (SSRIs) report they found them helpful, finds new research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London.
By
NIHR Maudsley BRC at 13 Mar 2025